Evidence map›Paper›PMID 42293675›Full record

ArticleFrontiers in public health2026

Predictive modeling of corporate financial risk and its implications for health economics and public health efficiency.

Wenyuan Zhi, Yao Kang

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wenyuan ZhiShanxi Vocational University of Engineering Science and Technology, Jinzhong, Shanxi, China.
Yao KangNanjing Pukou District Traditional Chinese Medicine Hospital, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study investigates the relationship between corporate financial risk and public health efficiency by developing a unified analytical framework that integrates financial risk prediction with health economic outcomes. We first establish a conceptual mechanism through which corporate financial instability affects public health systems via three primary pathways: direct effects through reduced healthcare funding and resource constraints, indirect effects through employment instability and changes in insurance coverage, and systemic effects through broader macroeconomic disruptions. Methods: Building on this framework, we propose the Risk Economic Health Nexus Model (REHNM), which combines probabilistic modeling, latent variable inference, and multimodal data integration to capture the complex and uncertain relationships between financial indicators and health outcomes. To account for temporal dynamics and external influences, we further introduce the Dynamic Risk Assessment Model (DRAM), enabling the model to track evolving financial conditions and their downstream health impacts. The Strategic Risk Health Integration Approach (SRHIA) is developed to translate predictive outputs into actionable insights for policymakers and health economists. Results and discussion: Empirical results demonstrate that the proposed framework improves predictive performance while providing interpretable insights into the linkage between financial risk and public health efficiency. Importantly, the model is designed as a decision support tool that can assist in early risk detection, resource allocation, and health system planning, thereby contributing to improved economic resilience and public health outcomes.

Indexed as

Efficiency, OrganizationalPublic HealthHumansModels, EconomicRisk Assessmentcorporate financial riskdecision support systemshealth economicspredictive modelingpublic health efficiencyrisk transmission mechanisms

Identifiers

PMID42293675
PMCPMC13253299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.